Skip to main content

Client News

Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB

21st January 2020

Abivax receives clearance from U.S. FDA to initiate clinical trials with ABX464 to treat moderate to severe ulcerative colitis

20th January 2020

Abivax: 2020 Financial Communication Calendar

20th January 2020

nova funds GmbH: Gesundheitsaktienfonds nova Steady HealthCare setzt ausgezeichnete Wertentwicklung fort

15th January 2020

Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

13th January 2020

AFFiRiS announces Phase 2 study in Parkinson’s and new focus on neurodegenerative diseases

10th January 2020

InflaRx to Present at Upcoming J.P. Morgan Annual Healthcare Conference

9th January 2020

InfanDx receives U.S. patent for its core technology on diagnosis of neonatal encephalopathy

9th January 2020

Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA

9th January 2020

Karl Naegler joins Wellington Partners as Managing Partner

8th January 2020